Economics; the
cost of providing blood increases on an annual basis.
We have observed locally a doubling of the price of
red cells over an approximately seven-year period,
which constitutes a 10% annualized compounded
rate of increase (Fig. 1). During this same period,
healthcare in the United States increased at an
annual 7%. In terms of the economics of blood, this
can largely be divided into two distinct components